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S122 DialysisCI, 1.65e12.81) were associated with a significantly higher risk of cardiovas-
cular mortality.
Conclusion: In CAPD patients, overweight was associated with uncontrolled
BP and uncontrolled SBP, and uncontrolled SBP was associated with an
increased risk of cardiovascular mortality. Patients with concurrent under-
weight and uncontrolled BP, as well as underweight and uncontrolled SBP
had significantly higher risk of cardiovascular mortality.http://dx.doi.org/10.1016/j.hkjn.2015.09.186
0141
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Objective: Type D personality is a stable and powerful predictor of
impaired quality of life and poor health outcomes in various patient
groups and healthy individuals. We attempted to assess the relation-
ships among Type D personality, illness perception, social support and
depression, and investigate the impact of Type D personality on quality
of life (QOL) in continuous ambulatory peritoneal dialysis (CAPD)
patients.
Methods: The demographic information, clinical data and laboratory find-
ings in CAPD patients in our PD center from September, 2012 to
September, 2013 were collected. Type D personality was assessed by the
Chinese 14-item Type D Personality Scale (DS14). Patients’ illness percep-
tion, social support, depression, and QOL were assessed by using the Brief
Illness Perception Questionnaire (Brief IPQ), social support rating scale
(SSRS), Beck Depression Inventory (BDI), and Short Form 36 (SF-36),
respectively.
Results: Of the 385 CAPD patients investigated, 137 (35.6%) patients had
a Type D Personality (Type Ds). Type Ds believed their illness had much
more serious consequences (7.67 2.64 vs. 6.27 3.45, P < 0.001), and
experience much more symptoms that they attributed to their illness
(7.11 3.58 vs. 5.93 2.59, P Z 0.023). Significant differences were
found between Type Ds and non-Type Ds in QOL (395.2 130.34 vs.
489.6 148.38, P < 0.001), social support (21.7 5.42 vs. 24.93 5.83,
P < 0.001), and depression (22.9% vs. 20.4%, P < 0.001). The correlation
analysis demonstrated that Type D was positively associated with depres-
sion (r Z 0.384, P < 0.01), while negatively associated with SF-36 score
(r Z .301, P < 0.01), and social support (r Z 0.254, P < 0.01). Using
multiple linear regression analysis, we found that Type D personality
(b Z 82.554, P < 0.001) was independently associated with SF-36
score.
Conclusion: Type D personality was a predictor of poor QOL in PD patients.
Our results suggest that intervention for Type Ds may benefit CAPD patients
in terms of QOL improvement.http://dx.doi.org/10.1016/j.hkjn.2015.09.1870143
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Background: Peritoneal fibrosis (PF) is an almost invariable consequence
of peritoneal dialysis (PD), which is an established alternative for the
replacement therapy of end-stage renal disease. In our previous study,
we found that the expression level of miR-200a were down-regulated in
fibrotic peritoneum and the epithelial-mesenchymal transition (EMT) pro-
cess of peritoneal mesothelial cell. However, the role of miR-200a in
EMT of peritoneal mesothelial cell and peritoneal fibrosis is largely
unknown.
Methods: Human peritoneal mesothelial cell line (HMrSV5) was cultured in
the presence or absence of TGF-b1. The protein expression levels of EMTindex and E-box-binding homeobox (ZEB) 1/2 were determined by western
blot. The level of miR-200a was determined by real-time PCR. miR-200a
mimic or inhibitor and it negative control RNA, were transfected into HMrSV5
cells using Liptofectamine 2000.
Results: We found that miR-200a mimic can attenuated TGF-b1 induced
peritoneal mesothelial cell EMT and synthesis of extracellular matrix. It
was also demonstrated that the miR-200a was responsible for protecting
peritoneal mesothelial cells from mesenchymal transition by targeting sup-
pression of ZEB1/2.
Conclusion: The results suggested that miR-200a may not only be a useful
biomarker of EMT in ovarian cancer, but also of potential therapeutic value
in peritoneal fibrosis.Fig. 1 AeB: EMT index expression after transfection of miR-200a mimic or in-
hibitor. CeD: ZEB1/2 expression after transfection of miR-200a mimic.
*P < 0.5, #P < 0.01.http://dx.doi.org/10.1016/j.hkjn.2015.09.1880144
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Background: Peritoneal fibrosis (PF) is an almost invariable consequence of
peritoneal dialysis (PD), which is an established alternative for the replace-
ment therapy of end-stage renal disease. We know that miR-200a belong to
miR-200 family, which is closely related to a variety of fibrotic diseases.
However, the role of miR-200a in peritoneal fibrosis is largely unknown.
Methods: The peritoneal fibrosis mouse model associated with PD was estab-
lished by intraperitoneal injection of lipopolysaccharide + 4.25% peritoneal
dialysate. The expression of miRNA was detected by microarray. The expres-
sion of miRNA profiles between fibrotic and normal peritoneal tissues was
compared (n Z 3 in each group). The differentially expressed miRNA
(miR-200a) was validated by realetime PCR in lager sample size cohorts
(n Z 15). The expressions of miR-200a were also detected in the epithe-
lialemesenchymal transition (EMT) process of peritoneal mesothelium cells.
Results: In mice model of PD, peritoneal tissue was markedly thickened and
with a massive extracellular matrix accumulation. By miRNA microarray
analysis, miRe200a was significantly down regulated (3.31 folds change,
